Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis.

Kai-Cheng ChangShih-Chieh ShaoShihchen KuoChen-Yi YangHui-Yu ChenYuk-Ying ChanHuang-Tz Ou

Published in: Cardiovascular diabetology (2020)

In real-world T2D patients, dulaglutide versus liraglutide was associated with better glycemic control and comparable effects on changes of weight, blood pressure, and liver and renal functions.

Keyphrases

type diabetes
glycemic control
end stage renal disease
blood pressure
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
cardiovascular disease
insulin resistance
metabolic syndrome
skeletal muscle
patient reported
weight gain